Halton Healthcare
Site: Bone Research and Education Centre

Contact Information
| Office Phone | 905-844-5677 |
| Toll Free Phone | To avoid long distance charges to a Halton Healthcare hospital, just dial local hospital number and request to be transferred |
| Crisis Phone | Call 911 in emergencies |
| Fax | 905-844-8966 |
| info@boneresearch.ca | |
| Website | www.boneresearch.ca |
| Social Media | Facebook, LinkedIn, X (Twitter), YouTube |
| Primary Contact | Tadacia James, Medical Office Administrator; Email: tadacia@boneresarch.ca |
Agency Information
| Legal Status | (50) Non Profit |
| Established | 2015 |
| Primary Executive | Doctor Aliya Khan, Professor of Clinical Medicine |
| Funding | Donations |
Description and Service Details
| Description (Service) | Provides clinical care with on site diagnosis and management of complex metabolic bone diseases, calcium and parathyroid diseases * clinical research will focus on developing new therapies for osteoporosis, renal osteodystrophy and parathyroid diseases * onsite multi-media learning centre for patients and physicians
|
| Hours | Mon-Thu 9am-5pm * Fri 9am-3pm |
| Areas Served | Halton Region |
| Boundaries | Halton Region and area |
| Eligibility | People of all ages who require health and medical services |
| Application | Medical referral required with all required information and supporting documentation (complete patient demographics, all lab results, all bone density tests, previous physician consult reports) |
| Languages | English |
| Fees | None |
Site Information
| Site Location | Oakville (Bronte Creek) |
| Located In Community | Oakville |
| Address & Map | |
| Intersection | Third Line and Dundas St W |
| Physical Access | Fully Accessible |
Categories and Classification
Copyright
| Copyright Information | This listing is copyright © 2025 Ontario Health atHome |
Agency Overview
Any omissions are unintentional and HIP disclaims any liability for unauthorized use or reproduction of any portion of this site. For a complete copyright and license statement please refer to our Terms of Use.
